On Friday, Zulily Inc (NASDAQ:ZU)’s shares inclined 3.84% to $14.06.
Zulily Inc (ZU) declared that Darrell Cavens, President and Chief Executive Officer, and Brian Swartz, Chief Financial Officer, will take part in the will take part in a question-and-answer session at the Goldman Sachs dotCommerce Day in New York, NY on Thursday, June 18, 2015 at 10:30 a.m. ET.
zulily, inc. operates as an online retailer in the United States, Canada, Australia, the United Kingdom, and internationally. The company provides merchandise to moms purchasing for their children, themselves, and their homes.
McDermott International (NYSE:MDR)’s shares dropped -0.52% to $5.72.
McDermott International (MDR) declared that it has been awarded a contract by Mexican state-owned petroleum company – Pemex. Per the contract McDermott will perform engineering, procurement, construction, installation and pre-commissioning of the Ayatsil-C replacement jacket and related deck installation.
The company stated that this large brownfield contract would be added to its second-quarter backlog. The project is predictable to complete in the fourth quarter of 2016.
Administration at McDermott added that this is the fourth contract that it has been awarded for the Ayatsil field. Last year, the company delivered the Ayatsil-B drilling platform. Earlier this year, the firm accomplished the installation of the Ayatsil-A offshore jacket, deck and piles.
The Ayatsil field is located in the Bay of Campeche and is the biggest discovery for Pemex. The company has plans of developing the field using four platforms.
McDermott primarily serves the worldwide offshore oil and gas field developments. The company’s services comprise front-end design and detailed engineering in addition to fabrication and installation of offshore drilling and production facilities. The company also installs marine pipelines and subsea production systems.
Additionally, the company provides project administration and procurement services. It operates in most of the major offshore oil and gas producing regions, counting the U.S., Mexico, Canada, the Middle East, India, the Caspian Sea and the Asia Pacific.
McDermott International, Inc. operates as an engineering, procurement, construction, and installation company worldwide. The company operates through three segments: Asia Pacific, Americas, and the Middle East. It focuses on designing and executing offshore oil and gas projects.
At the end of Friday’s trade, Plains All American Pipeline, L.P. (NYSE:PAA)‘s shares surged 0.78% to $45.11.
Plains All American Pipeline, L.P. (PAA) stated cleanup costs for the oil spill that took place last month nearly 20 miles west of Santa Barbara, CA. According to the partnership, the cleanup costs have reached $65 million so far and are running at the rate of $3 million per day.
Investors are wary about the adequate safety measures in the pipelines adopted by the Zacks Rank #5 (Strong Sell) midstream operator. As a result, shares of the partnership dropped 9.7% from May 19 to close at $44.76 yesterday.
Plains All American Pipeline, L.P., through with its auxiliaries, engages in the transportation, storage, terminal ling, and marketing of crude oil, natural gas liquids (NGL), natural gas, and refined products in the United States and Canada. The company operates in three segments: Transportation, Facilities, and Supply and Logistics. The Transportation segment transports crude oil and NGL through pipelines, gathering systems, trucks, and barges. As of December 31, 2014, this segment owned and leased 17,800 miles of active crude oil, and NGL and gathering systems; 29 million barrels of active and above-ground tank capacity; 800 trailers; 149 transport and storage barges; and 72 transport tugs.
Orexigen Therapeutics, Inc. (NASDAQ:OREX), ended its Friday’s trading session with -1.75% loss, and closed at $4.48.
Heather D. Turner gave notice of her resignation as Senior Vice President, General Counsel and Secretary of Orexigen Therapeutics, Inc. (OREX) Ms. Turner is relocating to the San Francisco Bay Area with her family. Chris Hazuka, Associate General Counsel, will assume the role of acting-General Counsel while the ongoing search for a replacement is accomplished. The Company anticipates the resignation to be effective on or about June 25, 2015.
Orexigen Therapeutics, Inc., a biopharmaceutical company, focuses on the development of pharmaceutical products in the United States. The company offers Contrave for the treatment of obesity. It has a partnership agreement with Takeda Pharmaceutical Company Limited to develop and commercialize Contrave in Canada and Mexico. Orexigen Therapeutics, Inc. was founded in 2002 and is headquartered in La Jolla, California.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should might occur.
